BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12447606)

  • 1. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.
    Higgs S; Williams CM; Kirkham TC
    Psychopharmacology (Berl); 2003 Feb; 165(4):370-7. PubMed ID: 12447606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
    Williams CM; Kirkham TC
    Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
    Darmani NA
    J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves.
    Kurihara J; Nishigaki M; Suzuki S; Okubo Y; Takata Y; Nakane S; Sugiura T; Waku K; Kato H
    Jpn J Pharmacol; 2001 Sep; 87(1):93-6. PubMed ID: 11676206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenteric vasodilation mediated by endothelial anandamide receptors.
    Wagner JA; Varga K; Járai Z; Kunos G
    Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth.
    Fride E; Ginzburg Y; Breuer A; Bisogno T; Di Marzo V; Mechoulam R
    Eur J Pharmacol; 2001 May; 419(2-3):207-14. PubMed ID: 11426843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats.
    Jamshidi N; Taylor DA
    Br J Pharmacol; 2001 Nov; 134(6):1151-4. PubMed ID: 11704633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol.
    Costa B; Colleoni M
    Eur J Pharmacol; 2000 Apr; 395(1):1-7. PubMed ID: 10781666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational analysis of feeding induced by Delta9-THC and anandamide.
    Williams CM; Kirkham TC
    Physiol Behav; 2002 Jun; 76(2):241-50. PubMed ID: 12044596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.
    Järbe TU; DiPatrizio NV; Li C; Makriyannis A
    Behav Pharmacol; 2007 Nov; 18(7):673-80. PubMed ID: 17912052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
    Wakley AA; Rasmussen EB
    Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
    Gallate JE; Saharov T; Mallet PE; McGregor IS
    Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA; Járai Z; Bátkai S; Kunos G
    Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
    Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
    Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.